RxDoctor Payments Data

Nicholas Iafe, MD

Retina Specialist · Brentwood, MONPI 1942733811

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (54.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Eyepoint US, Inc. at 33.2% of the total.

$9,222in general payments, 2019–2025

Across 108 payments — averaging $85.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eyepoint US, Inc.$3K
  • Carl Zeiss Meditec USA, Inc.$2K
  • AbbVie$1K
  • Dutch Ophthalmic, USA$953
  • Genentech USA, Inc.$591
  • Regeneron Healthcare Solutions, Inc.$438
  • plus $1K from 7 others

What the payments were for

  • Consulting fees$2,75030%
  • Travel & lodging$1,49516%
  • Food & beverage$4,97854%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,222 in reported general payments places this provider in the 75th percentile of 45 retina specialist providers in Missouri.

See all retina specialist providers in Missouri

Medicare billing

Part B allowed, 2024
$2,842,388
Medicare patients
975
Services billed
26,150

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate229$8,770
Bromfenac Sodium27$4,183
Ketorolac Tromethamine192$3,620
Difluprednate16$2,050
MoxifloxacinMoxifloxacin Hcl84$1,712
Atropine Sulfate42$1,565
Brimonidine Tartrate48$1,335
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat30$361
Dorzolamide Hcl29$339
Latanoprost30$220
Ofloxacin17$160
Timolol Maleate27$102
Diclofenac Sodium11$40

Paid to pharmacies, not to this prescriber.

Other retina specialist in Brentwood

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →